Penn Medicine's Dr. Donald O'Rourke describes advances being seen today in using CAR-T against glioblastoma

blonca9
Apr 29, 2024
1 min read

He says that intrathecal administration as well as taking a dual target approach are key factors that have led to improvements over previous attempts of using CAR-T against brain cancers.

Recent Posts

See All

RBC Global Healthcare Conference: Desk Strategist Chris McCarthy shares how institutional investors have been affected by policy and macro factors, and how they have been positioning around catalysts

RBC Global Healthcare Conference: Senior Biotech Analyst Luca Issi shares his thoughts on the current state of gene and cell therapy

RBC Global Healthcare Conference: RBC's Brian Abrahams shares his take on biotech and offers advice for companies on how to navigate these times of change

Penn Medicine's Dr. Donald O'Rourke describes advances being seen today in using CAR-T against glioblastoma

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight